Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 8CNS 4Lymphoid 3Head & Neck 3Gynecologic 3Thoracic 2Other hematologic neoplasm 2Other 2Sarcoma 1Other solid neoplasm 1Myeloid 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Small Cell Lung Carcinoma 1Radiation Pneumonitis 1Mesothelioma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Acetylcysteine × Thoracic × Clear all
NCT05986318 2026-03-09

RESPIRE-ILD

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Recruiting
98 enrolled
Thoracic

Lung Neoplasms, Lung Diseases, Interstitial, Radiation Pneumonitis

NCT00637624 2022-08-25

NAC-PNP

Rijnstate Hospital

Phase NA Terminated
69 enrolled
Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Mesothelioma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡